Aortic Aneurysms: Challenges and Unmet Needs
Endovascular Today
Comprehensive coverage of the latest in endovascular medicine, including clinical trials, new devices, & emerging tech.
In This Issue
Guest Medical Editors Andres Schanzer, MD, & Stéphan Haulon, MD, introduce our latest issue that highlights where the gaps are in aortic aneurysm care with a focus on unmet clinical needs across various anatomy. Plus: Superficial Venous Disease updates.
COVER STORIES
Tilo K?lbel, MD, and Joseph Bavaria, MD, discuss ascending and arch disease and weigh in on early diagnosis, areas of concern, and the future of treatment.
Drs. Tara M. Mastracci, Bijan Modarai, and Chandler A. Long share their perspectives on needed innovations for thoracic aortic care, including solutions for common or critical complications and more.
Drs. Tim Resch, Sara L. Zettervall, and Carlos Timaran discuss the future of thoracoabdominal management, prioritizing better understanding of patient selection, regulatory approvals, and improved access to care.
In a commentary on infrarenal repair, Drs. Javairiah Fatima and Nuno V. Dias consider outward forces exerted by available devices, hostile anatomies leading to inadequate seal, and endoleaks resulting in reintervention.
Giovanni Pratesi, MD—with colleagues Martina Bastianon, MD; Sara Di Gregorio, MD; and Gaddiel Mozetta, MD—and Kimberly Malka, MD, address unmet needs in iliac branch disease, including broader size ranges to avoid hybrid, open, or off-label repair for patients unfit for surgery, and more.
Kristina Giles, MD, and Aarathi Minisandram, MD, address the management of type II endoleak with a transcaval approach.
Jessica P. Simons, MD, offers technical, anatomic, and equipment selection considerations for percutaneous translumbar approaches to type II endoleak embolization.
David Kuwayama, MD, explores laser-assisted transendograft coil embolization to target vessel cannulation and coil delivery.
Harry Hok Yee Yu, MBBS, and Kevin Mani, MD, consider when and whether inferior mesenteric artery embolization during index EVAR is worthwhile.
Dominique Fabre, MD; Thomas J. Postiglione, MD; and Stéphan Haulon, MD, examine the role of artificial intelligence (AI) and automation in aortic aneurysm care and the potential to improve clinical outcomes.
SUPERFICIAL VENOUS DISEASE
Investigators Benjamin Cher, MD, and Andrea Obi, MD, offer commentary on their recently published analysis of the association between sex and clinician- and patient-reported outcomes after endovenous ablation.
Drs. Ramona Gupta, Suman M. Wasan, and Avianne Bunnell examine the treatment of recurrent varicose veins and explore the etiology of recurrence patterns, proper technique and imaging use, consistent follow-up, and patient education and compliance.
FEATURED TECHNOLOGY
Drs. Carlos Guevara, Leigh Ann O’Banion, and Eric Secemsky describe their experiences in treating calcified SFA and popliteal lesions using intravascular lithotripsy. | Sponsored by Shockwave Medical.
Drs. Nicole Ilonzo and Lorena De Marco present case studies showing use of the ClotTriever System in single-session removal of thrombus in upper and lower extremity DVT, without thrombolytics & w/minimal blood loss. | Sponsored by Inari Medical.
MEDICAL AFFAIRS CORNER
A Medical Affairs Corner article with Drs. Kathleen Gibson and Manj Gohel considers the patient experience in chronic venous disease via a patient testimonial and case experience with the VenaSeal? closure system. | Sponsored by Medtronic.
Literature Highlights
We review the European Society for Vascular Surgery’s inaugural recommendations on radiation safety and talk with Tara M. Mastracci, MD, about the importance of radiation safety and raising awareness.
DEPARTMENTS
In our featured interview, we spoke with Elika Kashef, MBBS, about her thoughts on patient safety, staff well-being, trauma and women’s health interventions, and ensuring future generations’ exposure to interventional therapy.
ONLINE EXCLUSIVE
Neginder Saini, DO, a diagnostic radiology resident, talks with Dr. Tam about her experiences in interventional radiology, including her pathway into clinical research, writing practice guidelines, her new role as President of the Society of Interventional Radiology, and more.
Environmental Health Innovator with +Impakt, EPEA, Economics Ministry Luxembourg, Technical University Delft, Technical University Munich
1 年The threat of burst aortic aneurysms could be greatly reduced if a clinical trial succeeds with an endovascular technique that delivers a naturally derived substance to a different target. ? The target is elastic fiber that makes arteries flexible. It can trigger aneurysms when damaged. The substance is Pentagalloyl Glucose (PGG) found in the peel and bark of the Pomegranate fruit. In 2007, Clemson University scientists discovered that PGG can heal aortic aneurysms by regenerating elastic fiber. After years of NIH-funded research a first-in-human clinical trial is starting this year. For details on the discovery and a link to the clinical trial see: https://www.natureoflongevity.com/restoringelasticinyourbody
Data Scientist
1 年Nurea
Co Founder & CEO at Incepto
1 年Proud to support with Incepto your research effort in the role of ai automation in aortic aneurysm care. Stéphan Haulon dominique fabre
Associate Professor of Surgery and Radiology | Division of Vascular and Endovascular Surgery
1 年Nice…! Stéphan Haulon and Andy Schanzer…!
Chairman & Chief Executive Officer at Madina International Trading Co. Ltd.
1 年Very insightful and Intersting article on an important topic, Aortic Aneurysm